Technological advancements to expand imaging options, surge in prevalence of chronic diseases, and benefits over traditional gamma cameras drive the growth of the mobile gamma cameras market
PORTLAND, Oregon, Sept. 9, 2019 /PRNewswire/ -- Allied Market Research published a report, titled, "Mobile Gamma Cameras Market by Product Type (Single-head Mobile Gamma Cameras, Dual-head Mobile Gamma Cameras, Triple-head Mobile Gamma Cameras, and Handheld Mobile Gamma Camera), Application (Cardiac Imaging, Breast Imaging, Thyroid Scanning, Kidney Scanning, Intraoperative Imaging, and Others), and End User (Hospital, Imaging Centers & Clinics, and Research Centers): Global Opportunity Analysis and Industry Forecast, 2019–2026." According to the report, the global mobile gamma cameras industry garnered $57.60 million in 2018, and is estimated to generate $82.41 million by 2026, registering a CAGR of 4.7% from 2019 to 2026.
Technological advancements to expand imaging options, surge in prevalence of chronic diseases, and benefits of mobile gamma cameras over traditional gamma cameras drive the market growth. However, side effects of mobile gamma cameras and strict regulatory processes hinder the growth of the market. On the other hand, portability, design advantages, and technological innovations create new opportunities in the global mobile gamma cameras market.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/5645
The single-head mobile gamma cameras segment to lead by 2026
Based on product type, the single-head mobile gamma cameras segment held the highest market share of the global mobile gamma cameras market in 2018, accounting for nearly two-thirds of the total market share, and is estimated to maintain its lead position in terms of revenue during the forecast period. This is due to its lower cost, affordability, and high efficiency leading to high adoption in hospitals and surgical centers. However, the triple-head mobile gamma camera segment is estimated to register the fastest growth rate with a CAGR of 6.9% from 2019 to 2026, owing to superior quality of images that offer high resolution and speed.
The cardiac imaging segment to maintain its highest share during the forecast period
Based on application, the cardiac imaging segment accounted for nearly one-third of the total share of the global mobile gamma cameras market in 2018, and will maintain its highest share during the forecast period. This is due to rise in cardiac disorders and mortality rate along with increase in cardiac disease severity. On the other hand, the intraoperative imaging segment is expected to grow at the fastest CAGR of 6.2% from 2019 to 2026, owing to increase in surgical procedures in the world with surge in prevalence of injuries, chronic diseases, and accidents along with offering surgical precision and improvements in clinical outcomes for patients.
North America to maintain its dominant position by 2026
North America held the major share, contributing to more than two-fifths of the total share of the global mobile gamma cameras market in 2018, and will maintain its dominant position by 2026. This is due to well-established healthcare infrastructure, rise in prevalence of cancer and cardiac disorder, and high rate of adoption of technologically advanced devices. However, Asia-Pacific is expected to grow at the fastest growth rate, registering with a CAGR of 6.2% from 2019 to 2026, owing to rise in prevalence of the chronic diseases, faster adoption of technology, and rise in prevalence of cardiopathies.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/5645
Torchbearers of the industry
- Dilon Technologies, Inc.
- General Electric Company (GE Healthcare)
- Digirad Corporation
- DDD-Diagnostic A/S
- GAEDE Medizinsysteme GmbH
- Adolesco AB
- MiE GmbH
- Gamma Medica, Inc.
- Crystal Photonics GmbH
- Oncovision
Access KNOWLEDGE TREE (Premium on-demand, subscription-based pricing model) at: https://www.alliedmarketresearch.com/knowledgetree
Knowledge tree is a cloud-based intelligence platform that offers more than 2,000 selective, off-the-shelf reports on niche markets to enable our clients gain deep insights on the latest trends, dynamic technologies, and emerging application areas.
Similar Reports:
Cardiac Biomarkers Testing Market: Global Opportunity Analysis and Industry Forecast, 2019–2026
Breast Biopsy Market: Global Opportunity Analysis and Industry Forecast, 2016-2023
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg
Share this article